论文部分内容阅读
摘要目的评价MRI引导下经尿道超声治疗人前列腺癌的可行性和安全性。材料与方法本试验性研究已获得伦理审查委员会的批准。8例局限性前列腺癌(Gleason评分≤7,前列腺特异抗原水平≤15μg/L)病人(年龄,49～60岁,平均60岁)入组,
Abstract Objective To evaluate the feasibility and safety of transurethral ultrasonography in the treatment of human prostate cancer under MRI guidance. Materials and Methods This pilot study has been approved by the Ethics Review Board. Eight patients with localized prostate cancer (Gleason score ≤7 and prostate specific antigen level ≤15 μg / L) (age, 49-60 years, average 60 years)